Seres Therapeutics, Inc. (MCRB) SEC Filings — 2025
16 SEC filings for Seres Therapeutics, Inc. (MCRB) in 2025.
Filings
- Seres Therapeutics Swings to Profit on VOWST Sale, Cash Up — 10-Q · Nov 5, 2025
- Seres Therapeutics Files 8-K for Other Events — 8-K · Oct 3, 2025
- Seres Therapeutics Files 8-K on Financials — 8-K · Aug 6, 2025
- Seres Therapeutics Q2 Loss Widens to $60.5M Amid Strategic Pivot — 10-Q · Aug 6, 2025
- Seres Therapeutics Announces Board and Executive Changes — 8-K · Jul 22, 2025
- Seres Therapeutics Files 8-K on Financials — 8-K · May 7, 2025
- Seres Therapeutics Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Seres Therapeutics Updates Fiscal Year End — 8-K · Apr 22, 2025
- Nestlé to Acquire Seres Therapeutics for $1.9B — 8-K · Apr 14, 2025
- Seres Therapeutics DEFA14A: Executive Compensation Details — DEFA14A · Apr 4, 2025
- Seres Therapeutics, Inc. 8-K Filing — 8-K · Mar 13, 2025
- Seres Therapeutics Files 2024 10-K — 10-K · Mar 13, 2025
- Seres Therapeutics Announces Board and Executive Changes — 8-K · Feb 27, 2025
- Seres Therapeutics Announces Board and Officer Changes — 8-K · Feb 6, 2025
- Seres Therapeutics, Inc. 8-K Filing — 8-K · Jan 13, 2025
- Seres Therapeutics Files 8-K on Operations and Financials — 8-K · Jan 10, 2025